CN114380776B - Sesquiterpene electrophilic natural product, and separation preparation method and application thereof - Google Patents
Sesquiterpene electrophilic natural product, and separation preparation method and application thereof Download PDFInfo
- Publication number
- CN114380776B CN114380776B CN202111302496.4A CN202111302496A CN114380776B CN 114380776 B CN114380776 B CN 114380776B CN 202111302496 A CN202111302496 A CN 202111302496A CN 114380776 B CN114380776 B CN 114380776B
- Authority
- CN
- China
- Prior art keywords
- electrophilic
- natural product
- target
- preparation
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种倍半萜类亲电天然产物及其分离制备方法和应用。所述半萜类亲电天然产物,其化学结构式如式(I)所示;本发明利用亲电探针,结合常用的天然化合物分离提取的手段,成功地从银杏粗提取物中分离得到了准分子离子峰[M+H]+为263.1275的亲电天然产物单体。经结构表征,本发明分离制备的亲电天然产物是一个含有不饱和内酯环和邻羰基五元呋喃环的、母核结构完全不同于银杏内酯K的新型倍半萜亲电天然产物,所述亲电天然产物作用于Keap1‑Nrf2信号通路的活性,具有较强的抗炎生物活性,是一个理想的新型半胱氨酸残基共价抑制剂的先导化合物,在治疗炎症,肿瘤,神经衰退,心血管疾病或代谢性疾病等方面具有较大的应用前景。
The invention discloses a sesquiterpene electrophilic natural product, its separation preparation method and application. The semiterpenoid electrophilic natural product has a chemical structural formula as shown in formula (I); the present invention utilizes an electrophilic probe in conjunction with the usual means of separating and extracting natural compounds, and successfully separates it from the crude extract of Ginkgo biloba An electrophilic natural product monomer with a quasi-molecular ion peak [M+H] + of 263.1275. Through structural characterization, the electrophilic natural product separated and prepared in the present invention is a new type of sesquiterpene electrophilic natural product containing an unsaturated lactone ring and a five-membered furan ring adjacent to carbonyl, and whose core structure is completely different from ginkgolide K. The electrophilic natural product acts on the activity of the Keap1-Nrf2 signaling pathway, has strong anti-inflammatory biological activity, and is an ideal lead compound of a new covalent inhibitor of cysteine residues, which can be used in the treatment of inflammation, tumors, It has great application prospects in neurodegeneration, cardiovascular disease or metabolic disease.
Description
技术领域technical field
本发明涉及生物医药技术领域,具体地,涉及一种倍半萜类亲电天然产物及其分离制备方法和应用,更具体地,涉及一种银杏来源的新型倍半萜亲电天然产物的分离制备及其在制备抗炎药物中的应用。The present invention relates to the technical field of biomedicine, in particular, to a sesquiterpene electrophilic natural product and its separation and preparation method and application, more specifically, to the separation of a novel sesquiterpene electrophilic natural product derived from ginkgo biloba Preparation and its application in the preparation of anti-inflammatory drugs.
背景技术Background technique
与蛋白活性相关的半胱氨酸残基,具有高亲核性的巯基基团,是一个理想的共价结合位点。因此,很多的共价抑制剂都是通过修饰靶蛋白半胱氨酸残基发挥作用的。亲电天然产物(Electrophilic natural products,ENP)是半胱氨酸共价抑制剂的一大重要来源,通过修饰蛋白半胱氨酸残基发挥抗炎抗肿瘤等一系列的作用,具有很好的成药性质。然而,目前亲电天然产物的开发还停留在偶然发现的阶段。The cysteine residue associated with protein activity, with a highly nucleophilic sulfhydryl group, is an ideal covalent binding site. Therefore, many covalent inhibitors work by modifying cysteine residues of target proteins. Electrophilic natural products (ENP) are an important source of cysteine covalent inhibitors, which play a series of roles such as anti-inflammatory and anti-tumor by modifying protein cysteine residues, and have a good Medicinal properties. However, the development of electrophilic natural products is still at the stage of serendipitous discovery.
银杏提取物,指的是从银杏中提取的有效物质,含有银杏总黄酮,银杏内酯等物质。有扩张血管,保护血管内皮组织、调节血脂、保护低密度脂蛋白、抑制PAF(血小板激活因子),抑制血栓形成、清除自由基等作用。据报道,在银杏提取物中带有α,β-不饱和酮亲电结构的天然产物只有银杏内酯K(Beek,T.A.v.,Chemical analysis of Ginkgo bilobaleaves and extracts.Journal of Chromatography A 2002,967,21-55;Singh,B.;Kaur,P.;Gopichand;Singh,R.D.;Ahuja,P.S.,Biology and chemistry of Ginkgobiloba.Fitoterapia 2008,79(6),401-418.);因此,需要开发更多新颖的活性天然亲电产物作为半胱氨酸共价抑制剂的先导化合物。Ginkgo extract refers to the active substances extracted from Ginkgo biloba, which contain ginkgo total flavonoids, ginkgolides and other substances. It has the functions of expanding blood vessels, protecting vascular endothelial tissue, regulating blood lipids, protecting low-density lipoprotein, inhibiting PAF (platelet activating factor), inhibiting thrombosis, and scavenging free radicals. It is reported that only ginkgolide K (Beek, T.A.v., Chemical analysis of Ginkgo bilobaleaves and extracts.Journal of Chromatography A 2002, 967, 21 -55; Singh, B.; Kaur, P.; Gopichand; Singh, R.D.; Ahuja, P.S., Biology and chemistry of Ginkgobiloba. Fitoterapia 2008, 79(6), 401-418.); The active natural electrophilic product of , as a lead compound for cysteine covalent inhibitors.
发明内容Contents of the invention
本发明的目的在于克服现有技术中存在的上述缺陷和不足,提供一种倍半萜类亲电天然产物。The object of the present invention is to overcome the above-mentioned defects and deficiencies in the prior art, and provide a sesquiterpene electrophilic natural product.
本发明的另一目的在于提供所述倍半萜类亲电天然产物的分离制备方法。Another object of the present invention is to provide a method for the separation and preparation of the sesquiterpenoid electrophilic natural product.
本发明的再一目的在于提供所述倍半萜类亲电天然产物的应用。Another object of the present invention is to provide the application of the sesquiterpene electrophilic natural product.
本发明的上述目的是通过以下技术方案给予实现的:Above-mentioned purpose of the present invention is given to realize by following technical scheme:
一种倍半萜类亲电天然产物,其化学结构式如式(I)所示:A sesquiterpene electrophilic natural product, its chemical structural formula is as shown in formula (I):
本发明式(I)所述亲电天然产物是银杏来源的新型亲电天然产物,是一类含有五元不饱和内酯环和邻羰基五元呋喃环的、母核结构完全不同于银杏内酯K的新型倍半萜亲电天然产物。所述新型亲电天然产物作用于Keap1-Nrf2信号通路的活性,具有较强的抗炎生物活性(EC50≈15μM),是一个理想的新型半胱氨酸残基共价抑制剂的先导化合物。The electrophilic natural product described in the formula (I) of the present invention is a novel electrophilic natural product derived from Ginkgo biloba. Novel sesquiterpene electrophilic natural products of ester K. The novel electrophilic natural product acts on the activity of the Keap1-Nrf2 signaling pathway, has strong anti-inflammatory biological activity (EC 50 ≈15 μM), and is an ideal lead compound for a new covalent inhibitor of cysteine residues .
本发明还提供所述倍半萜类亲电天然产物的分离制备方法,包括如下步骤:The present invention also provides a method for separating and preparing the sesquiterpene electrophilic natural product, comprising the steps of:
S1.将亲电探针与银杏粗提取物形成天然产物-探针复合物,采用色谱串联多级质谱进行检测;选取准分子离子峰[M+H]+为612.3103的银杏-探针目标亲电天然产物,减去亲电探针的分子量,获得目标亲电天然产物的准分子离子峰[M+H]+为263.1275;所述色谱采用Thermo Scientific UltiMate 3000 HPLC,液相条件:Hypersil Gold Dim C18柱,100×2.1mm,1.9μm,流动相:A相:含0.1%甲酸的水溶液,B相:乙腈;流速:0.3mL/min,梯度洗脱,梯度洗脱条件如表1所示;所述质谱采用Thermo Fisher QExactive,质谱检测条件如表2所示;S1. Form a natural product-probe complex between the electrophilic probe and the crude extract of Ginkgo biloba, and detect it by chromatography-tandem mass spectrometry; select the Ginkgo-probe target pro-probe with the quasi-molecular ion peak [M+H] + of 612.3103 Electron natural product, minus the molecular weight of electrophilic probe, the quasi-molecular ion peak [M+H] of the target electrophilic natural product obtained is 263.1275; the chromatography adopts Thermo Scientific UltiMate 3000 HPLC, liquid phase condition: Hypersil Gold Dim C18 column, 100×2.1mm, 1.9μm, mobile phase: phase A: aqueous solution containing 0.1% formic acid, phase B: acetonitrile; flow rate: 0.3mL/min, gradient elution, gradient elution conditions are shown in Table 1; The mass spectrometry adopts Thermo Fisher QExactive, and the mass spectrometry detection conditions are as shown in Table 2;
S2.在步骤S1相同的色谱和质谱条件下对银杏粗提取物进行高分辨一级扫描,提取目标亲电天然产物的准分子离子峰[M+H]+为263.1275的色谱峰,获得目标亲电天然产物在色谱柱上的保留时间为13.10分钟;S2. Under the same chromatographic and mass spectrometric conditions as step S1, the crude extract of Ginkgo biloba is subjected to high-resolution first- level scanning, and the quasi-molecular ion peak [M+H] of the target electrophilic natural product is extracted with a chromatographic peak of 263.1275 to obtain the target electrophilic The retention time of the electric natural product on the chromatographic column is 13.10 minutes;
S3.在步骤S1相同的色谱和质谱条件下对银杏粗提取物进行DAD紫外全扫描液质检测,获得目标亲电天然产物的紫外吸收波长范围为240~270nm;S3. Under the same chromatographic and mass spectrometric conditions as step S1, the crude extract of Ginkgo biloba is subjected to DAD ultraviolet full-scan liquid-mass detection, and the ultraviolet absorption wavelength range of the target electrophilic natural product is 240-270nm;
S4.使用制备液相对银杏粗提取物中的目标亲电天然产物进行分离和制备,确定目标亲电天然产物在该制备液相条件下的出峰时间是24.98~25.12分钟;所述制备液相条件为Agilent ZORBAX SB-C18,9.4×250mm,5μm;S4. Use the preparation solution to separate and prepare the target electrophilic natural product in the crude extract of Ginkgo biloba, and determine that the peak eluting time of the target electrophile natural product under the conditions of the preparation liquid phase is 24.98 to 25.12 minutes; the preparation liquid phase The condition is Agilent ZORBAX SB-C18, 9.4×250mm, 5μm;
S5.采用中低压制备液相色谱对银杏粗提取物进行第一次分离提纯;所述中低压制备液相色谱采用0.1%甲酸水和甲醇洗脱体系、C18自装柱,填料80g,流速12mL/min,0.1%甲酸水的梯度比例设置为25%~80%,过柱分离时间为150分钟,利用步骤S4制备液相中总结的目标亲电天然产物出峰时间,收集所有含目标亲电天然产物的流份,减压旋蒸收集;所述C18自装柱为YMC,填料:ODS-A,微孔径12nm,颗粒径50μm;S5. The Ginkgo crude extract is separated and purified for the first time by medium and low pressure preparative liquid chromatography; the medium and low pressure preparative liquid chromatography adopts 0.1% formic acid water and methanol elution system, C18 self-packing column, packing 80g, flow rate 12mL /min, the gradient ratio of 0.1% formic acid water is set to 25% to 80%, and the column separation time is 150 minutes. Use the peak time of the target electrophile natural product summarized in the preparation of the liquid phase in step S4 to collect all the samples containing the target electrophile Fractions of natural products were collected by rotary evaporation under reduced pressure; the C18 self-packing column was YMC, packing: ODS-A, micropore diameter 12nm,
S6.采用薄层层析对步骤S6含目标亲电天然产物的所有流份进行二次分离提纯;所述薄层层析的展开剂为体积比2:1的环己烷:乙酸乙酯,展开时间为45分钟;将得到的所有条带都分别收集并洗脱,并对每一个条带都进行液质联用分析,获取准分子离子峰[M+H]+为263.1275的目标亲电天然产物的纯品。S6. Perform secondary separation and purification of all fractions containing the target electrophilic natural product in step S6 by thin-layer chromatography; the developer of the thin-layer chromatography is cyclohexane:ethyl acetate with a volume ratio of 2:1, The development time was 45 minutes; all the obtained bands were collected and eluted separately, and each band was analyzed by liquid chromatography-mass spectrometry to obtain the target electrophile with a quasi-molecular ion peak [M+H] + of 263.1275 Pure products of natural products.
优选地,步骤S3所述紫外全扫描液质检测的质谱仪器型号是Bruker timsTOF,液相仪器型号是Thermo U3000。Preferably, the mass spectrometry instrument model of the ultraviolet full-scan liquid mass detection in step S3 is Bruker timsTOF, and the liquid phase instrument model is Thermo U3000.
优选地,步骤S6所述薄层层析的制备板规格为1mm。Preferably, the preparation plate size of the thin layer chromatography described in step S6 is 1mm.
优选地,步骤S6所述洗脱为采用丙酮洗脱。Preferably, the elution in step S6 is elution with acetone.
本发明所述新型亲电天然产物作用于Keap1-Nrf2信号通路的活性,具有较强的抗炎生物活性(EC50≈15μM),是一个理想的新型半胱氨酸残基共价抑制剂的先导化合物。因此,本发明还提供所述倍半萜类亲电天然产物在制备抗炎产品中的应用。The novel electrophilic natural product of the present invention acts on the activity of the Keap1-Nrf2 signaling pathway, has strong anti-inflammatory biological activity (EC 50 ≈15 μM), and is an ideal new covalent inhibitor of cysteine residues. lead compound. Therefore, the present invention also provides the use of the sesquiterpene electrophilic natural product in the preparation of anti-inflammatory products.
本发明还提供所述倍半萜类亲电天然产物在制备心血管疾病药物中的应用。The present invention also provides the application of the sesquiterpene electrophilic natural product in the preparation of cardiovascular disease medicine.
本发明还提供一种抗炎产品,所述产品含有上述式(I)所示的倍半萜类亲电天然产物。The present invention also provides an anti-inflammatory product, which contains the sesquiterpene electrophilic natural product represented by the above formula (I).
本发明前期建立了基于报告离子和活性巯基反应基团的新型亲电分子探针(CN112321489A),能与天然粗提取物或者细胞提取物等复杂基质中微量的亲电天然产物高效结合形成天产-探针复合物。结合色谱串联多级质谱的检测手段,天产-探针复合物在二级扫描过程中以特定的方式碎裂,在二级图谱中稳定地给出特征性的报告离子峰(m/z=126.1277)并计算出相应天然产物化合物与探针反应的产物的精确分子量(<5ppm),以及相应的天然产物的精确分子量(<5ppm);并依据上述精确分子量预测其精确分子式;能实现高效、快速、准确地发现天然基质中微量的亲电天然产物,而且利用该亲电探针的示踪功能可以指导微量亲电天然产物从复杂天然基质中的分离。本发明前期从多种天然植物提取物(苍耳提取物、银杏提取物、甜瓜蒂提取物、灵芝提取物、杭白菊提取物和藤黄提取物)中发现了许多文献报道过和文献未曾报道过的潜在活性亲电天然产物,验证了亲电探针高效发现潜在活性亲电天然产物的强大功能。本发明上述倍半萜类亲电天然产物的分离制备方法即给出了一种利用亲电探针指导分离亲电天然产物的方法实例。In the early stage of the present invention, a new type of electrophilic molecular probe (CN112321489A) based on reporter ions and active sulfhydryl reactive groups was established, which can efficiently combine with trace electrophilic natural products in complex matrices such as natural crude extracts or cell extracts to form natural products. - Probe complex. Combined with the detection method of chromatographic tandem mass spectrometry, the Tianchan-probe complex is fragmented in a specific way during the secondary scanning process, and a characteristic reporter ion peak (m/z = 126.1277) and calculate the exact molecular weight (<5ppm) of the product reacted with the corresponding natural product compound and the probe, and the exact molecular weight (<5ppm) of the corresponding natural product; and predict its exact molecular formula according to the above-mentioned exact molecular weight; Quickly and accurately discover trace electrophilic natural products in natural matrices, and use the tracer function of the electrophilic probe to guide the separation of trace electrophilic natural products from complex natural matrices. In the early stage of the present invention, many documents have been reported and documents have not been reported from various natural plant extracts (Cocklebur extract, Ginkgo biloba extract, Melon pedicle extract, Ganoderma lucidum extract, Chrysanthemum chrysanthemum extract and Garcinia cambogia extract) The potential active electrophilic natural products have been verified, and the powerful function of electrophilic probes to efficiently discover potentially active electrophilic natural products has been verified. The separation and preparation method of the above-mentioned sesquiterpenoid electrophilic natural products of the present invention provides an example of a method for using electrophilic probes to guide the separation of electrophilic natural products.
本发明利用亲电探针的示踪功能,结合天然产物的常用分离手段,成功地从天然银杏粗提取物中分离得到了准分子离子峰[M+H]+为263.1275的新型的亲电天然产物单体。本发明研究表明,该亲电天然产物是一类含有五元不饱和内酯环和邻羰基五元呋喃环的、母核结构完全不同于银杏内酯K的新型倍半萜亲电天然产物,具有如式(I)所示结构。本发明还验证了该银杏来源的新型亲电天然产物作用于Keap1-Nrf2信号通路的活性,具有较强的抗炎生物活性(EC50≈15μM),是一个理想的新型半胱氨酸残基共价抑制剂的先导化合物。The present invention utilizes the tracing function of the electrophilic probe, combined with the usual separation means of natural products, successfully separates and obtains a new type of electrophilic natural product with a quasi-molecular ion peak [M+H] + of 263.1275 from the crude extract of natural ginkgo biloba. product monomer. The research of the present invention shows that the electrophilic natural product is a new type of sesquiterpene electrophilic natural product that contains a five-membered unsaturated lactone ring and an adjacent carbonyl five-membered furan ring, and whose core structure is completely different from ginkgolide K. It has the structure shown in formula (I). The present invention also verifies that the novel electrophilic natural product derived from ginkgo acts on the activity of the Keap1-Nrf2 signaling pathway, has strong anti-inflammatory biological activity (EC 50 ≈15 μM), and is an ideal novel cysteine residue Lead compounds for covalent inhibitors.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明提供了一种银杏来源的新型呋喃倍半萜类亲电天然产物,其化学结构式如式(I)所示,所述亲电天然产物作用于Keap1-Nrf2-ARE信号通路的活性,具有较高的激活Keap1-Nrf2通路的活性,具有较强的抗炎活性(EC50≈15μM),也具有较好的水溶性和稳定性,该新型化合物是一个理想的以针对半胱氨酸残基产生共价抑制为药理机制的抗炎新药的先导化合物。The present invention provides a novel furan sesquiterpene electrophilic natural product derived from Ginkgo biloba, its chemical structural formula is as shown in formula (I), and the electrophilic natural product acts on the activity of Keap1-Nrf2-ARE signaling pathway, and has High activity of activating the Keap1-Nrf2 pathway, strong anti-inflammatory activity (EC 50 ≈15μM), and good water solubility and stability, the new compound is an ideal target for cysteine residues A lead compound for generating new anti-inflammatory drugs based on covalent inhibition as a pharmacological mechanism.
附图说明Description of drawings
图1为银杏粗提取物一级扫描色谱图。(上)银杏提取物总离子流图;(下)提取[M+H]+为263.1275的色谱峰。Figure 1 is the primary scanning chromatogram of ginkgo crude extract. (Top) Total ion chromatogram of Ginkgo biloba extract; (Bottom) Extracted [M+H]+ chromatographic peak of 263.1275.
图2为银杏粗提取物的质谱全扫描图和[M+H]+为263.1275的色谱峰;(上)银杏粗提取物的质谱全扫描图;(下)提取[M+H]+为263.1275的色谱峰。Figure 2 is the mass spectrum full scan of ginkgo crude extract and [M+H] + is 263.1275 chromatographic peak; (top) mass spectrum full scan of ginkgo crude extract; (bottom) extraction [M+H] + is 263.1275 chromatographic peaks.
图3银杏粗提取物的高分辨率质谱全扫描图。Figure 3 Full scan of high-resolution mass spectrometry of ginkgo crude extract.
图4为提取[M+H]+为263.1275的色谱峰的高分辨质谱图。Fig. 4 is the high-resolution mass spectrum of the chromatographic peak extracted with [M+H] + being 263.1275.
图5为银杏粗提取物的DAD质谱全扫描图。(1)质谱全扫描图(箭头:目标亲电天然产物峰);(2)190-400nm紫外波长下银杏粗提取物的吸收情况;(3)254nm紫外波长下银杏粗提取物的吸收情况(箭头:目标亲电天然产物峰);(4)270nm紫外波长下银杏粗提取物的吸收情况。Figure 5 is a full scan of the DAD mass spectrum of ginkgo crude extract. (1) Full scan of mass spectrum (arrow: target electrophilic natural product peak); (2) Absorption of Ginkgo crude extract at 190-400nm UV wavelength; (3) Absorption of Ginkgo crude extract at 254nm UV wavelength ( Arrow: target electrophilic natural product peak); (4) Absorption of Ginkgo crude extract at 270nm ultraviolet wavelength.
图6为目标亲电天然产物在254、270和260nm下的紫外吸收情况。(箭头:目标亲电天然产物峰)。Fig. 6 is the ultraviolet absorption of the target electrophilic natural product at 254, 270 and 260 nm. (Arrows: target electrophilic natural product peaks).
图7为新型亲电天然产物1H NMR谱图。Fig. 7 is a 1 H NMR spectrum of a novel electrophilic natural product.
图8为新型亲电天然产物的13C NMR谱图。Fig. 8 is a 13 C NMR spectrum of a novel electrophilic natural product.
图9为新型亲电天然产物的Dept135谱图。Figure 9 is the Dept135 spectrum of a novel electrophilic natural product.
图10为新型亲电天然产物的Dept 90谱图。Figure 10 is the
图11为新型亲电天然产物的HMBC谱图。Figure 11 is the HMBC spectrum of the novel electrophilic natural product.
图12为新型亲电天然产物的HSQC谱图。Figure 12 is the HSQC spectrum of a novel electrophilic natural product.
图13为新型亲电天然产物的H-H Noesy谱图。Figure 13 is the H-H Noesy spectrum of the novel electrophilic natural product.
图14为新型亲电天然产物的H-H Cosy谱图。Figure 14 is the H-H Cozy spectrum of the novel electrophilic natural product.
图15为新型亲电天然产物的cLogP值。Figure 15 is the cLogP value of the novel electrophilic natural product.
图16-17为新型亲电天然产物与亲电巯基探针反应制备的同一样品在不同时间段进样得到的质谱图。Figures 16-17 are the mass spectrograms of the same sample prepared by reacting the novel electrophilic natural product with the electrophilic thiol probe at different time periods.
具体实施方式Detailed ways
以下结合说明书附图和具体实施例来进一步说明本发明,但实施例并不对本发明做任何形式的限定。除非特别说明,本发明采用的试剂、方法和设备为本技术领域常规试剂、方法和设备。The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments, but the embodiments do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field.
除非特别说明,以下实施例所用试剂和材料均为市购。Unless otherwise specified, the reagents and materials used in the following examples are commercially available.
亲电探针根据专利CN112321489A进行制备。The electrophilic probe is prepared according to the patent CN112321489A.
银杏粗提取物购买自宝鸡辰光生物(宝鸡辰光20200501)Ginkgo biloba crude extract was purchased from Baoji Chenguang Biotechnology (Baoji Chenguang 20200501)
实施例1应用亲电探针与银杏粗提取物共价结合形成天产-探针复合物Example 1 Application of electrophilic probes to covalently bind Ginkgo biloba crude extracts to form natural natural-probe complexes
1、在5mL反应容器中,加入银杏提取物、探针化合物(1.2eq)和L-抗坏血酸(1.5eq)后,用1mL超干无水甲醇做溶剂(反应溶剂需事先除氧,充入氩气),超声使反应混合物全溶后,通入氩气除氧,立即旋紧盖子,封上封口膜。常温下搅拌22小时后,停止搅拌,立即旋干反应液。用质谱级的甲醇制样,配成1ppm的样品溶液,按以下液相与质谱的方法分析银杏天产-探针复合物。1. In a 5mL reaction vessel, add Ginkgo biloba extract, probe compound (1.2eq) and L-ascorbic acid (1.5eq), and use 1mL ultra-dry anhydrous methanol as a solvent (the reaction solvent needs to be deoxygenated before filling with argon After the reaction mixture was fully dissolved by ultrasonication, argon gas was introduced to remove oxygen, and the cap was immediately tightened and sealed with a parafilm. After stirring at room temperature for 22 hours, the stirring was stopped, and the reaction solution was spin-dried immediately. Samples were prepared with mass spectrometry-grade methanol to prepare a 1ppm sample solution, and the Ginkgo natural product-probe complex was analyzed according to the following liquid phase and mass spectrometry methods.
仪器:超高压液相-高分辨质谱仪;超高效液相型号:Thermo ScientificUltiMate 3000HPLC;高分辨质谱型号:Thermo Fisher QExactive。Instrument: ultra-high pressure liquid phase-high resolution mass spectrometer; ultra high performance liquid phase model: Thermo ScientificUltiMate 3000HPLC; high resolution mass spectrometer model: Thermo Fisher QExactive.
液相条件:Hypersil Gold Dim C18柱,100×2.1mm,1.9μm。流动相:A相:水溶液(含0.1%甲酸),B相:乙腈;流速:0.3mL/min,梯度洗脱。Liquid phase conditions: Hypersil Gold Dim C18 column, 100×2.1 mm, 1.9 μm. Mobile phase: Phase A: aqueous solution (containing 0.1% formic acid), phase B: acetonitrile; flow rate: 0.3mL/min, gradient elution.
银杏天产-探针复合物梯度洗脱条件见表1。See Table 1 for the gradient elution conditions of the Ginkgo natural product-probe complex.
银杏天产-探针复合物质谱检测条件见表2Ginkgo natural-probe complex mass spectrometry detection conditions are shown in Table 2
表1银杏天产-探针复合物梯度洗脱条件Table 1 Ginkgo natural product-probe complex gradient elution conditions
Retention time:保留时间;Flow:流速;A:乙腈;B:0.1%甲酸水Retention time: retention time; Flow: flow rate; A: acetonitrile; B: 0.1% formic acid water
表2银杏天产-探针复合物质谱检测条件Table 2 Ginkgo biloba-probe complex mass spectrometry detection conditions
结果从银杏粗提取物中发现了54个潜在的活性亲电天然产物,其中包括已知亲电产物,银杏内酯K。本发明随机选取了准分子离子峰[M+H]+为612.3103的目标天产-探针复合物,扣除了探针分子本身的分子量,由此可知该目标亲电天然产物的[M+H]+为263.1275。Results 54 potential active electrophilic natural products were found from the crude extract of Ginkgo biloba, including the known electrophilic product, ginkgolide K. The present invention randomly selects the target natural product-probe complex whose quasi-molecular ion peak [M+H] + is 612.3103, and deducts the molecular weight of the probe molecule itself, so it can be known that the [M+H] of the target electrophilic natural product ] + is 263.1275.
2、在相同的色谱和质谱条件下对银杏粗提取物进行了一级扫描,提取了准分子离子峰[M+H]+为263.1275的目标亲电天然产物的的色谱峰,如图1所示,可知该目标亲电天然产物在色谱柱上的保留时间为13.10分钟。2. Under the same chromatographic and mass spectrometric conditions, the crude extract of Ginkgo biloba was scanned at the first level, and the quasi-molecular ion peak [M+H ] was extracted The chromatographic peak of the target electrophilic natural product of 263.1275, as shown in Figure 1 It can be seen that the retention time of the target electrophilic natural product on the chromatographic column is 13.10 minutes.
3、紧接着对银杏粗提取物做了一个DAD紫外全扫描液质检测,质谱仪器型号是Bruker timsTOF;液相仪器型号是Thermo U3000,色谱柱和色谱条件同上。3. Immediately afterwards, a DAD ultraviolet full-scan liquid mass detection was performed on the crude extract of ginkgo. The mass spectrometry instrument model was Bruker timsTOF; the liquid phase instrument model was Thermo U3000, and the chromatographic column and chromatographic conditions were the same as above.
结果如图2~图4所示,图2为银杏粗提取物的质谱全扫描图和[M+H]+为263.1275的色谱峰,图3为银杏粗提取物的高分辨率质谱全扫描图,图4为提取[M+H]+为263.1275的色谱峰的高分辨质谱图,可知图3中的12号峰为目标亲电天然产物峰。本发明首先定位到目标亲电天然产物是银杏粗提取物全扫描图(图3)中的12号峰;然后DAD质谱全扫描图及目标亲电天然产物在254、270和260nm下的紫外吸收情况如图5~图6所示,发现[M+H]+为263.1275的该目标亲电天然产物有紫外吸收,吸收范围为240~270nm,在254nm下有最强的紫外吸收。The results are shown in Figures 2 to 4, Figure 2 is the full scan of the mass spectrum of the crude extract of Ginkgo biloba and the chromatographic peak with [M+H] + being 263.1275, and Figure 3 is the full scan of the high-resolution mass spectrum of the crude extract of Ginkgo biloba , Figure 4 is the high-resolution mass spectrum of the chromatographic peak extracted with [M+H] + being 263.1275, it can be known that peak No. 12 in Figure 3 is the peak of the target electrophilic natural product. The present invention locates the target electrophilic natural product at first and is the No. 12 peak in the full scan figure of Ginkgo biloba crude extract (Fig. 3); As shown in Figures 5-6, it was found that the target electrophilic natural product with [M+H] + of 263.1275 has ultraviolet absorption, the absorption range is 240-270nm, and the strongest ultraviolet absorption is at 254nm.
4、考虑到该目标亲电天然产物在色谱柱(Agilent ZORBAX Eclipse Plus C18柱,2.1mm×50mm,1.8μm)上的分离度情况比较理想,周围基本上没有干扰峰。因此,首先考虑把分离条件放大到制备液相(Agilent Technologies PrepStar,Agilent ZORBAX SB-C18,9.4×250mm,5μm)上,直接对银杏粗提取物中该目标亲电天然产物进行分离和制备。由于该银杏粗提取物的成分非常复杂,在该制备柱上的分离度不够,因此不能直接对该银杏粗提取物用制备液相去分离制备。但是在采用制备液相分离目标产物这一步实验中,确定了目标亲电天然产物在该制备液相条件下的出峰时间是24.98~25.12分钟。4. Considering that the resolution of the target electrophilic natural product on a chromatographic column (Agilent ZORBAX Eclipse Plus C18 column, 2.1mm×50mm, 1.8μm) is ideal, there are basically no interference peaks around. Therefore, it is first considered to expand the separation conditions to the preparative liquid phase (Agilent Technologies PrepStar, Agilent ZORBAX SB-C18, 9.4×250mm, 5μm), and directly separate and prepare the target electrophilic natural product in the crude extract of Ginkgo biloba. Since the components of the ginkgo crude extract are very complex, the separation degree on the preparation column is not enough, so the ginkgo crude extract cannot be directly separated and prepared by the preparative liquid phase. However, in the experiment of separating the target product by using the preparative liquid phase, it was determined that the peak eluting time of the target electrophilic natural product was 24.98-25.12 minutes under the conditions of the preparative liquid phase.
5、本发明改变分离策略,先对银杏粗提取物用0.1%甲酸水和甲醇洗脱体系、中低压制备液相、C18自装柱(品牌:YMC,填料:ODS-A,微孔径12nm,颗粒径50μm)进行第一次分离提纯。填料80g,流速12mL/min,0.1%甲酸水的梯度比例设置为25%-80%,过柱分离时间为150分钟。本发明对收集到的所有流份,利用上述在制备液相中总结出来的目标亲电天然产物的出峰时间,收集所有含该目标亲电天然产物的流份,减压旋蒸收集。接下来本发明再利用该目标亲电天然产物的紫外特性用硅胶正相制备板对上述含目标组分的所有流份进行二次分离提纯(制备板规格为1mm,环己烷:乙酸乙酯为2:1的展开剂30mL)。当上述含目标组分的所有流份进行正相硅胶分离完全后(展开时间约为45分钟),本发明将制备板上的所有条带都分别收集并用丙酮进行洗脱,接着对每一个条带都进行了液质联用分析,从而总结目标条带在制备板上的位置,最终得到准分子离子峰[M+H]+为263.1275的目标亲电天然产物的纯品。5. The present invention changes the separation strategy. First, the ginkgo crude extract is eluted with 0.1% formic acid water and methanol, and the medium and low pressure is used to prepare the liquid phase, and the C18 self-packing column (brand: YMC, filler: ODS-A, micropore diameter 12nm, particle size of 50 μm) for the first separation and purification. Filler 80g, flow rate 12mL/min, gradient ratio of 0.1% formic acid water is set to 25%-80%, column separation time is 150 minutes. For all fractions collected in the present invention, all fractions containing the target electrophilic natural product are collected by using the peak eluting time of the target electrophilic natural product summarized in the preparation liquid phase, and collected by rotary evaporation under reduced pressure. Next, the present invention utilizes the ultraviolet characteristics of the target electrophilic natural product to carry out secondary separation and purification of all fractions containing the target components with a silica gel normal phase preparation plate (preparation plate specification is 1 mm, cyclohexane: ethyl acetate 2:1 developer 30mL). After all the fractions containing the above-mentioned target components are completely separated by normal phase silica gel (the development time is about 45 minutes), all the bands on the preparation plate are collected and eluted with acetone in the present invention, and then each band is All the bands were analyzed by liquid chromatography-mass spectrometry to summarize the position of the target band on the preparation plate, and finally a pure product of the target electrophilic natural product with a quasi-molecular ion peak [M+H]+ of 263.1275 was obtained.
6、通过质谱、一维谱、二维谱等检测手段表征和确认该目标亲电天然产物的结构。1HNMR谱图如图7所示,1H NMR(600MHz,CDCl3)δ8.06(s,1H),7.47(d,J=1.5Hz,1H),7.12–7.04(m,1H),6.78(d,J=1.2Hz,1H),5.00(ddd,J=7.5,4.1,2.1Hz,1H),3.51(d,J=3.3Hz,1H),2.86–2.72(m,2H),1.94(d,J=1.6Hz,2H),1.89–1.77(m,2H),1.64(ddd,J=9.1,6.8,4.5Hz,2H),1.60(s,3H),1.58(dd,J=9.6,5.0Hz,1H),1.54(dd,J=8.7,4.4Hz,1H),1.52–1.50(m,1H),1.28(s,3H),1.05(d,J=6.6Hz,2H),0.90(t,J=7.0Hz,1H),0.09(s,1H).;6. Characterize and confirm the structure of the target electrophilic natural product by mass spectrometry, one-dimensional spectrum, two-dimensional spectrum and other detection means. The 1 HNMR spectrum is shown in Figure 7, 1 H NMR (600MHz, CDCl 3 ) δ8.06(s, 1H), 7.47(d, J=1.5Hz, 1H), 7.12–7.04(m, 1H), 6.78 (d,J=1.2Hz,1H),5.00(ddd,J=7.5,4.1,2.1Hz,1H),3.51(d,J=3.3Hz,1H),2.86–2.72(m,2H),1.94( d, J=1.6Hz, 2H), 1.89–1.77(m, 2H), 1.64(ddd, J=9.1, 6.8, 4.5Hz, 2H), 1.60(s, 3H), 1.58(dd, J=9.6, 5.0Hz, 1H), 1.54(dd, J=8.7, 4.4Hz, 1H), 1.52–1.50(m, 1H), 1.28(s, 3H), 1.05(d, J=6.6Hz, 2H), 0.90( t,J=7.0Hz,1H),0.09(s,1H).;
13C NMR谱图如图8所示,13C NMR(151MHz,CDCl3)δ194.85(s),174.28(s),149.18(s),147.08(s),144.26(s),129.79(s),127.64(s),108.62(s),79.30(s),40.87(s),37.86(s),31.21(s),29.74(d,J=8.4Hz),22.70(s),19.24(s),14.13(s),10.66(s).; The 13 C NMR spectrum is shown in Figure 8, 13 C NMR (151MHz, CDCl 3 ) δ194.85(s), 174.28(s), 149.18(s), 147.08(s), 144.26(s), 129.79(s ), 127.64(s), 108.62(s), 79.30(s), 40.87(s), 37.86(s), 31.21(s), 29.74(d, J=8.4Hz), 22.70(s), 19.24(s ), 14.13(s), 10.66(s).;
Dept135谱图如图9所示,13C NMR(151MHz,CDCl3)δ149.17(s),147.08(s),144.26(s),108.62(s),79.30(s),77.23(s),19.24(s),14.13(s),10.66(s).4个季碳,8个伯/叔碳,3个仲碳;The spectrum of Dept135 is shown in Figure 9, 13 C NMR (151MHz, CDCl 3 ) δ149.17(s), 147.08(s), 144.26(s), 108.62(s), 79.30(s), 77.23(s), 19.24(s), 14.13(s), 10.66(s). 4 quaternary carbons, 8 primary/tertiary carbons, 3 secondary carbons;
Dept 90谱图如图10所示,13C NMR(151MHz,CDCl3)δ149.18(s),147.09(d,J=4.2Hz),144.25(s),108.61(s),79.29(s),29.76(s).6个叔碳;The spectrum of
HMBC谱图如图11所示,HSQC谱图如图12所示,H-H Noesy谱图如图13所示,H-HCosy谱图如图14所示;经以上多方面的结构表征,确定所述目标亲电天然产物的结构的结构式如式(I)所示:HMBC spectrogram as shown in Figure 11, HSQC spectrogram as shown in Figure 12, H-H Noesy spectrogram as shown in Figure 13, H-HCosy spectrogram as shown in Figure 14; The structural formula of the structure of target electrophilic natural product is as shown in formula (I):
是一种母核结构完全不同于已知亲电产物-银杏内酯K的新型呋喃倍半萜亲电天然产物。 It is a new type of furan sesquiterpene electrophilic natural product whose core structure is completely different from the known electrophile product - ginkgolide K.
实施例2新型呋喃倍半萜亲电天然产物性能测试Example 2 Performance Test of Novel Furan Sesquiterpene Electrophilic Natural Products
一、抗炎活性测试1. Anti-inflammatory activity test
具体方法如下:The specific method is as follows:
(一)药物&试剂准备:(1) Drug & reagent preparation:
1、药物稀释至所需工作浓度;1. Dilute the drug to the required working concentration;
2、试剂&荧光素酶工作底物配制:2. Reagent & luciferase working substrate preparation:
(1)ATP buffer:配1M的Tris,用HCl调节pH至7.5,配制成1M Tris-Cl(pH7.5)。(1) ATP buffer: prepare 1M Tris, adjust the pH to 7.5 with HCl, and prepare 1M Tris-Cl (pH7.5).
(2)Luciferin buffer:把0.34g KH2PO4粉末加入到500mL ddH2O中,用KOH调节pH至7.8。如此配制成5mM KH2PO4(PH7.8)。(2) Luciferin buffer: Add 0.34g KH 2 PO 4 powder into 500mL ddH 2 O, and adjust the pH to 7.8 with KOH. This was formulated as 5 mM KH 2 PO 4 (PH 7.8).
(3)荧光素酶工作底物;(3) Luciferase working substrate;
(4)0.5%NP-40:NP40很黏稠,NP-40先用1X PBS稀释至20%,再取20%NP-40用1XPBS稀释至0.5%。(4) 0.5% NP-40: NP40 is very viscous, NP-40 is first diluted to 20% with 1X PBS, and then 20% NP-40 is diluted to 0.5% with 1XPBS.
(5)5mg/mL MTT(需避光配制):用1X PBS溶解好后,过0.22um过滤器除菌。分装成1mL/管,-20℃长期储存。(5) 5mg/mL MTT (to be prepared in the dark): After dissolving in 1X PBS, pass through a 0.22um filter to sterilize. Aliquot into 1mL/tube and store at -20°C for a long time.
(二)检测luc实验步骤:(2) Experimental steps for detecting luc:
前一天铺板:Plank the day before:
1)细胞500rpm离心5min,用1mL培养液重悬,将细胞浓度调整至3*10^5个/mL并吹打均匀;1) Cells were centrifuged at 500rpm for 5min, resuspended in 1mL of culture medium, adjusted to 3*10^5 cells/mL and pipetted evenly;
2)用排枪进行细胞铺板,铺板96孔平底板,200ul/孔;2) Use a row gun to plate the cells, plate a 96-well flat bottom plate, 200ul/well;
实验当日:On the day of the experiment:
3)设置三个复孔的同时设置空白对照孔以及溶剂对照孔,按顺序往各个孔中加入2ul药物稀释物,加完一块板后轻敲96孔板四边混匀;3) Set up three duplicate wells and set up blank control wells and solvent control wells at the same time, add 2ul drug dilutions to each well in sequence, and tap the four sides of the 96-well plate to mix evenly after adding one plate;
4)37℃,5%CO2培养6h。6h后镜下观察细胞生长状况;4) Cultivate at 37° C., 5% CO 2 for 6 hours. After 6 hours, the cell growth status was observed under the microscope;
5)1600rpm离心5min,弃液;(此时可冻存于-80℃)5) Centrifuge at 1600rpm for 5min, discard the solution; (at this time, it can be frozen at -80°C)
6)每孔加入50ul 0.5%NP40,微量振荡器中档震20min;6) Add 50ul of 0.5% NP40 to each well, shake on the medium gear of the micro shaker for 20min;
7)每孔吸取10ul至全白96孔板中;7) Pipette 10ul per well into a pure white 96-well plate;
8)测荧光值(ZH LAB,Promega,GLOMAX 96microplate luminometer);8) Measure the fluorescence value (ZH LAB, Promega, GLOMAX 96microplate luminometer);
9)计算抑制率:(1-药物组/溶剂组)*100%9) Calculate the inhibition rate: (1-drug group/solvent group)*100%
(三)检测MTT实验步骤:(3) Detection of MTT experimental steps:
前一天铺板:Plank the day before:
1)细胞500rpm离心5min,用1mL培养液重悬后,将细胞浓度调整至1*10^5个/mL并吹打均匀;1) Cells were centrifuged at 500rpm for 5min, resuspended in 1mL of culture medium, adjusted to 1*10^5 cells/mL and pipetted evenly;
2)用排枪进行细胞铺板,铺板96孔平底板,200ul/孔;2) Use a row gun to plate the cells, plate a 96-well flat bottom plate, 200ul/well;
实验当日:On the day of the experiment:
3)设置空白对照孔、溶剂对照孔以及lysis孔,按顺序往各个孔中加入2ul药物稀释物并轻敲边缘混匀;3) Set blank control wells, solvent control wells and lysis wells, add 2ul drug dilutions to each well in sequence and tap the edge to mix;
4)37℃,5%CO2培养48h,48h后镜下观察细胞生长状况;4) Culture at 37°C, 5% CO 2 for 48 hours, and observe the cell growth status under the microscope after 48 hours;
5)lysis孔加入20ul 10X lysis solution,避光每孔加入10ul MTT,并轻敲边缘混匀;5) Add 20ul 10X lysis solution to the analysis well, add 10ul MTT to each well in the dark, and tap the edge to mix;
6)37℃,5%CO2培养4H;6) Culture at 37°C, 5% CO2 for 4 hours;
7)1600rpm离心5min,用移液枪轻轻吸掉上清,注意不要吸到沉淀;7) Centrifuge at 1600rpm for 5min, gently suck off the supernatant with a pipette, and be careful not to suck up the precipitate;
8)每孔加入150ul DMSO(上海生工产),微量振荡器中档震15min;8) Add 150ul DMSO (manufactured by Shanghai Sangong) to each well, and vibrate for 15 minutes in the middle gear of the micro shaker;
9)490nm测吸光值;9) Measure the absorbance at 490nm;
10)计算致死率:(溶剂组-药物组)/(溶剂组-LYSIS组)*100%10) Calculate the lethal rate: (solvent group-drug group)/(solvent group-LYSIS group)*100%
结果:所述新型呋喃倍半萜亲电天然产物活性测试的结果如下表3所示,表明所述新型呋喃倍半萜亲电天然产物作用于Keap1-Nrf2-ARE信号通路的活性,并具有较强的抗炎活性(EC50=15μM)。Result: the result of described novel furan sesquiterpene electrophilic natural product activity test is shown in the following table 3, shows that described novel furan sesquiterpene electrophilic natural product acts on the activity of Keap1-Nrf2-ARE signaling pathway, and has relatively Strong anti-inflammatory activity (EC 50 =15 μM).
表3新型呋喃倍半萜亲电天然产物活性测试结果Table 3 Activity test results of novel furan sesquiterpene electrophilic natural products
二、水溶性测试2. Water Solubility Test
测试方法:将式(I)所示倍半萜类亲电天然产物的化学结构式导入ligandscout软件,计算其cLogP值,结果如图15所示,该天然产物的cLogP计算值为2.909,cLogP值越小水溶性越佳,表明该天然产物具有较好的水溶性。Test method: import the chemical structural formula of sesquiterpene electrophilic natural product shown in formula (I) into ligandscout software, calculate its cLogP value, the result is as shown in Figure 15, the cLogP calculated value of this natural product is 2.909, and the cLogP value is more The smaller the water solubility, the better, indicating that the natural product has better water solubility.
三、稳定性测试3. Stability test
图16和图17所示两张质谱数据均来自本发明半萜类亲电天然产物与亲电巯基探针反应制备的同一样品,263.1275是该天然产物单体的准分子离子峰[M+H]+,两张图谱是同一样品在不同时间段(2021.09.14、2021.09.27)进样得到的数据,图谱显示263.1275的峰强度都在E9,没有明显变化,说明该天然产物没有随着时间的变化发生降解等,由此可以说明这个天然产物的稳定性比较好。The two mass spectrum data shown in Figure 16 and Figure 17 all come from the same sample prepared by the reaction of the semiterpenoid electrophilic natural product and the electrophilic thiol probe of the present invention, and 263.1275 is the quasi-molecular ion peak [M+H of the natural product monomer ] + , the two spectra are the data obtained from the injection of the same sample at different time periods (2021.09.14, 2021.09.27 ). Degradation occurs over time, which shows that the stability of this natural product is relatively good.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111302496.4A CN114380776B (en) | 2021-11-04 | 2021-11-04 | Sesquiterpene electrophilic natural product, and separation preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111302496.4A CN114380776B (en) | 2021-11-04 | 2021-11-04 | Sesquiterpene electrophilic natural product, and separation preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114380776A CN114380776A (en) | 2022-04-22 |
| CN114380776B true CN114380776B (en) | 2023-05-23 |
Family
ID=81195594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111302496.4A Active CN114380776B (en) | 2021-11-04 | 2021-11-04 | Sesquiterpene electrophilic natural product, and separation preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114380776B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101209952A (en) * | 2006-12-31 | 2008-07-02 | 中国科学院上海药物研究所 | Sesquiterpene compound and its composition, method of extracting from plant and application thereof |
| CN102199159A (en) * | 2011-03-21 | 2011-09-28 | 贵州大学 | Method for separating and purifying ginkgolide C in ginkgo root bark |
| CN112321489A (en) * | 2020-10-15 | 2021-02-05 | 中山大学 | An electrophilic molecular probe based on active sulfhydryl group and reporter ion and its preparation method and application |
-
2021
- 2021-11-04 CN CN202111302496.4A patent/CN114380776B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101209952A (en) * | 2006-12-31 | 2008-07-02 | 中国科学院上海药物研究所 | Sesquiterpene compound and its composition, method of extracting from plant and application thereof |
| CN102199159A (en) * | 2011-03-21 | 2011-09-28 | 贵州大学 | Method for separating and purifying ginkgolide C in ginkgo root bark |
| CN112321489A (en) * | 2020-10-15 | 2021-02-05 | 中山大学 | An electrophilic molecular probe based on active sulfhydryl group and reporter ion and its preparation method and application |
Non-Patent Citations (2)
| Title |
|---|
| Abell, Andrew D.等.Stereospecific formation of tetrahydrofurans from substituted 2,8-dioxabicyclo[3.2.1]oct-3-ylmethanols.《Australian Journal of Chemistry》.1984,第37卷(第2期),395-407. * |
| Yinyi Gao等.A Nucleophilic Chemical Probe Targeting Electrophilic Functional Groups in an Untargeted Way to Explore Cysteine Modulators in Natural Products.《ACS Chem. Biol.》.2022,第17卷1685-1690. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114380776A (en) | 2022-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kerns et al. | Profiling taxanes in Taxus extracts using LC/MS and LC/MS/MS techniques | |
| Zhao et al. | Dual ultrasonic-assisted dispersive liquid–liquid microextraction coupled with microwave-assisted derivatization for simultaneous determination of 20 (S)-protopanaxadiol and 20 (S)-protopanaxatriol by ultra high performance liquid chromatography–tandem mass spectrometry | |
| Darcsi et al. | Structure elucidation of a process-related impurity of dapoxetine | |
| US6358996B1 (en) | Stable isotope labeling of paclitaxel | |
| CN114380776B (en) | Sesquiterpene electrophilic natural product, and separation preparation method and application thereof | |
| WO1994025449A1 (en) | Oxidation products of cephalomannine | |
| CN111499676A (en) | 4-Chloro-3-nitro-1-p-toluenesulfonyl-7-azaindole derivative and its preparation method and application | |
| RU2276669C2 (en) | Method for chromatography separation of paclitaxel and cefalomannin | |
| CN105294786B (en) | The synthetic method of clindamycin sulfoxide | |
| Fernández et al. | Synthesis and antifungal activity of bile acid-derived oxazoles | |
| Manner et al. | Spiro-bicyclo [2.2. 2] octane derivatives as paclitaxel mimetics. Synthesis and toxicity evaluation in breast cancer cell lines | |
| CN114539292B (en) | A novel podophyllotoxin splicing anti-tumor active molecular compound and its preparation method and application | |
| CN111499652B (en) | Artemisinin-piperazine-furanone derivative as well as preparation method and application thereof | |
| CN116284198A (en) | A kind of oleanane type triterpene derivative and its preparation method and application | |
| CN113292542A (en) | Rosuvastatin calcium intermediate impurity and preparation method thereof | |
| Kadir et al. | Conformational analysis of diterpene lactone andrographolide towards reestablishment of its absolute configuration via theoretical and experimental ECD and VCD methods | |
| CN112250694A (en) | Thiazolopyridinone compound and preparation method and application thereof | |
| Jimenez-Romero et al. | Reassignment of the absolute configuration of plakinidone from the sponge consortium Plakortis halichondrioides–Xestospongia deweerdtae using a combination of synthesis and a chiroptical approach | |
| CN112321642A (en) | Ruidexiwei related substance and preparation method and application thereof | |
| Zhang et al. | Highly efficient and simultaneous production of thirteen taxanes from Taxus× media and mining of their new bioactivity | |
| Xie et al. | Synthesis, biological evaluation and mechanism study based on network pharmacology of amino acids esters of 20 (S)-protopanaxadiol as novel anticancer agents | |
| Yemback et al. | Lupane derivatives: Design, isolation, synthesis and evaluation of antiplasmodial activity against Plasmodium falciparum 3D7 strain | |
| CN116354824B (en) | Rosin alkane type diterpenoid compound, preparation method, pharmaceutical composition and application thereof | |
| CN108409691A (en) | A kind of Cabazitaxel crystal form HDC-1 and preparation method thereof | |
| CN116162122B (en) | A dehydroepiandrosterone triazole derivative and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |